13F-HR filed by Artal Group S.A.
Artal Group S.A. filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 91 holding rows worth $4,504,900,000.
- Accession
- 0001140361-17-006297
- Filer
- CIK 1053906
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 93 entries on the cover page, a total value of $4,504,900,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,504,900,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerStichting Administratiekantoor Westend028-15028
- included managerWestend S.A.028-15029
- included managerArtal International Management S.A.028-15031
- included managerArtal International S.C.A.028-15033
- included managerInvus Public Equities Advisors, LLC028-11522
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BLUE BUFFALO PET PRODS INC | 09531U102 | COM | 87,460,875 | $2,102,559,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 57,517,977 | $795,474,000 | thousands by filing date | |
| WEIGHT WATCHERS INTL INC | 948626106 | COM | 29,443,300 | $337,126,000 | thousands by filing date | |
| METLIFE INC COM | 59156R108 | Stock | 1,750,000 | $94,308,000 | thousands by filing date | call |
| CELGENE CORP | 151020104 | COM | 700,000 | $81,025,000 | thousands by filing date | call |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 180,000 | $66,076,000 | thousands by filing date | call |
| INCYTE CORP COM | 45337C102 | Stock | 650,000 | $65,176,000 | thousands by filing date | |
| Wells Fargo & Company | 949746101 | COM | 1,000,000 | $55,110,000 | thousands by filing date | call |
| JPMorgan Chase & Co | 46625H100 | COM | 600,000 | $51,774,000 | thousands by filing date | call |
| Bristol-Myers Squibb Company | 110122108 | COM | 800,000 | $46,752,000 | thousands by filing date | call |
| CHIPOTLEMEXICANGRILLI | 169656105 | STOK | 115,000 | $43,392,000 | thousands by filing date | call |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 350,000 | $42,823,000 | thousands by filing date | call |
| BIOGEN INC COM | 09062X103 | Stock | 150,000 | $42,537,000 | thousands by filing date | call |
| Bank of America Corp | 060505104 | COM | 1,600,000 | $35,360,000 | thousands by filing date | call |
| ISHARES TR | 464287184 | CHINA LG-CAP ETF | 1,000,000 | $34,710,000 | thousands by filing date | call |
| Walmart Inc. | 931142103 | COM | 500,000 | $34,560,000 | thousands by filing date | call |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 750,000 | $31,298,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 350,000 | $28,994,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 422,536 | $26,070,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 600,000 | $25,038,000 | thousands by filing date | call |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 200,000 | $24,470,000 | thousands by filing date | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 250,000 | $21,953,000 | thousands by filing date | |
| ATHENE HOLDING LTD | G0684D107 | CL A | 400,000 | $19,196,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 500,000 | $18,720,000 | thousands by filing date | |
| International Business Machines Corporation | 459200101 | COM | 100,000 | $16,599,000 | thousands by filing date | call |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 600,000 | $16,458,000 | thousands by filing date | call |
| Pfizer Inc. | 717081103 | COM | 500,000 | $16,240,000 | thousands by filing date | call |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 200,000 | $14,734,000 | thousands by filing date | call |
| Eli Lilly and Company | 532457108 | COM | 200,000 | $14,710,000 | thousands by filing date | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 150,000 | $12,426,000 | thousands by filing date | call |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,000,000 | $12,270,000 | thousands by filing date | |
| ZTO EXPRESS CAYMAN INC | 98980A105 | SPONSORED ADS A | 1,000,000 | $12,070,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 100,000 | $11,575,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 250,000 | $11,210,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,250,000 | $10,988,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 100,000 | $10,027,000 | thousands by filing date | call |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 200,000 | $9,566,000 | thousands by filing date | call |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 300,000 | $9,108,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,750,000 | $8,698,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,000,000 | $8,240,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 500,000 | $8,090,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 516,879 | $7,903,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 150,000 | $7,659,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 200,000 | $7,488,000 | thousands by filing date | call |
| AVEXIS INC | 05366U100 | COM | 150,000 | $7,160,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 500,000 | $7,100,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 700,000 | $6,930,000 | thousands by filing date | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 250,000 | $6,360,000 | thousands by filing date | call |
| Morgan Stanley | 617446448 | COM | 150,000 | $6,338,000 | thousands by filing date | call |
| BLUEBIRD BIO INC | 09609G100 | COM | 100,000 | $6,170,000 | thousands by filing date | call |
| NEKTAR THERAPEUTICS | 640268108 | COM | 500,000 | $6,135,000 | thousands by filing date | call |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 150,000 | $5,805,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 200,000 | $5,486,000 | thousands by filing date | |
| Bowater Inc | 09066L105 | COMMON STOCKS | 1,282,050 | $4,628,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 850,000 | $4,505,000 | thousands by filing date | |
| ELFBEAUTYINC | 26856L103 | STOK | 150,000 | $4,341,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 200,000 | $4,088,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 546,278 | $4,042,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 100,000 | $3,870,000 | thousands by filing date | call |
| ACCELERON PHARMA INC | 00434H108 | COM | 150,000 | $3,828,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 100,000 | $3,803,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 200,000 | $3,770,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 300,000 | $3,726,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 246,054 | $3,555,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 50,000 | $3,516,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 250,000 | $3,278,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 250,000 | $3,245,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 650,000 | $3,231,000 | thousands by filing date | call |
| LOXO ONCOLOGY INC | 548862101 | COM | 100,000 | $3,212,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 160,000 | $2,968,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 251,300 | $2,953,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 150,000 | $2,543,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 50,000 | $2,495,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 675,000 | $2,390,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 500,000 | $2,300,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 50,000 | $2,221,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 256,400 | $2,159,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 500,000 | $2,060,000 | thousands by filing date | call |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 100,000 | $1,885,000 | thousands by filing date | call |
| MEDICINES CO | 584688105 | COM | 50,000 | $1,697,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 81,600 | $1,669,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 500,000 | $1,590,000 | thousands by filing date | |
| NANTKWEST INC | 63016Q102 | COM | 225,000 | $1,287,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 300,000 | $1,215,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 100,000 | $1,140,000 | thousands by filing date | |
| DIMENSION THERAPEUTICS INC | 25433V105 | COM | 234,493 | $1,020,000 | thousands by filing date | |
| ACHAOGEN INC | 004449104 | COM | 60,000 | $781,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 500,000 | $630,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 200,000 | $560,000 | thousands by filing date | |
| ONCOCYTE CORP | 68235C107 | COM | 64,102 | $452,000 | thousands by filing date | |
| COLUCID PHARMACEUTICALS INC | 19716T101 | COM | 5,575 | $203,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-17-006297 | this filing | 2017-02-14 | acceptance time not in the bulk data set |